Professor Nina Tirnitz-Parker is a Research Academic and Head of the Liver Disease and Regeneration Group in the Curtin Medical School and Liver Cancer Program Lead at the Curtin Health Innovation Research Institute. The group mainly works on basic, translational and clinical research in liver disease, fibrosis and cancer, with a particular focus on the cutting-edge technology platforms (i) single cell/nucleus RNA sequencing, (ii) patient-derived organoid drug screening, and (iii) the NanoString GeoMx Digital Spatial Profiler for spatial transcriptomics/proteomics. Prof Tirnitz-Parker is Director of the Liver Cancer Collaborative (LCC, www.livercancercollaborative.au) and has served the Gastroenterological Society of Australia (GESA) in numerous senior leadership roles over the years, including Board Director (2019-20, 2021-23) and Chair of the GESA Research & Grants Committee (2019-20), Australian Liver Association Executive Committee Member (2015-17, 2017-19) and National Scientific Meeting Convenor (2013, 2018).